Announce Date | 09/23/2025 |
EPS Normalized Actual | $48.71 (Miss by $-2.02) |
EPS GAAP Actual | $48.71 (Miss by $-2.02) |
Revenue Actual | $6.24273B |
Revenue Surprise | Beat by $6242.73M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Aug 2030 | 246.51 | 16.34 | 238.11981 | 252.76259 | 4 |
Aug 2030 | 246.51 | 16.34 | 238.31425 | 253.61323 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Aug 2025) | 50.02 | 50.02 | 6.24273B | 0.6% | 6242.73M |
FQ2 2025 (May 2025) | 36.33 | 36.33 | 4.46434B | 5.13% | 4464.34M |
FQ1 2025 (Feb 2025) | 28.29 | 28.29 | 3.95201B | 100% | 3952.01M |
FQ4 2024 (Nov 2024) | 33.4 | 33.4 | 4.27964B | 100% | 4279.64M |
FQ3 2024 (Aug 2024) | 53.28 | 53.28 | 6.20538B | 100% | 6205.38M |
FQ2 2024 (Apr 2024) | 37.73 | 37.73 | 4.23548B | 100% | 4235.48M |
FQ2 2022 (May 2022) | 29.93 | 29.93 | 3.86522B | 100% | 3865.22M |
FQ3 2022 (Aug 2022) | 41.81 | 41.81 | 5.34836B | 100% | 5348.36M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Aug 2028) | 71.5236 | -- | 69.78359 | 73.37383 | 9 |
FQ2 2028 (May 2028) | 71.5236 | -- | 69.78359 | 73.37383 | 9 |
FQ1 2028 (Feb 2028) | 50.4786 | -- | 49.25057 | 51.78442 | 9 |
FQ4 2027 (Nov 2027) | 43.53 | -- | 42.47101 | 44.65607 | 10 |
FQ3 2027 (Aug 2027) | 64.99 | -- | 64.99 | 64.99 | 12 |
FQ2 2027 (May 2027) | 43.97333 | -- | 43.97333 | 43.97333 | 11 |
FQ1 2027 (Feb 2027) | 0 | -- | 0 | 0 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Aug 2028) | 8.32B | -- | 8.17B | 8.49B | 6 |
FQ2 2028 (May 2028) | 8.13B | -- | 7.97B | 8.29B | 6 |
FQ1 2028 (Feb 2028) | 7.93B | -- | 7.78B | 8.09B | 6 |
FQ4 2027 (Nov 2027) | 7.75B | -- | 7.6B | 7.9B | 10 |
FQ3 2027 (Aug 2027) | 7.11B | -- | 7.11B | 7.11B | 11 |
FQ2 2027 (May 2027) | 5.06B | -- | 5.06B | 5.06B | 18 |
FQ1 2027 (Feb 2027) | 4.44B | -- | 4.39B | 4.51B | 15 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Aug 2025) | 50.02 | 50.02 | 100% | |
FQ2 2025 (May 2025) | 36.33 | 36.33 | 100% | |
FQ1 2025 (Feb 2025) | 28.29 | 28.29 | 100% | |
FQ4 2024 (Nov 2024) | 33.4 | 33.4 | 100% | |
FQ3 2024 (Aug 2024) | 53.28 | 53.28 | 100% | |
FQ2 2024 (Apr 2024) | 37.73 | 37.73 | 100% | |
FQ2 2022 (May 2022) | 29.93 | 29.93 | 100% | |
FQ3 2022 (Aug 2022) | 41.81 | 41.81 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Aug 2025) | $0B | $6.24B | $6242.73M | 100% |
FQ2 2025 (May 2025) | $0B | $4.46B | $4464.34M | 100% |
FQ1 2025 (Feb 2025) | $0B | $3.95B | $3952.01M | 100% |
FQ4 2024 (Nov 2024) | $0B | $4.28B | $4279.64M | 100% |
FQ3 2024 (Aug 2024) | $0B | $6.21B | $6205.38M | 100% |
FQ2 2024 (Apr 2024) | $0B | $4.24B | $4235.48M | 100% |
FQ2 2022 (May 2022) | $0B | $3.87B | $3865.22M | 100% |
FQ3 2022 (Aug 2022) | $0B | $5.35B | $5348.36M | 100% |